The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 12,801–12,900 of 31,469
Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
Baba, T. (2025) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12630 · Cited by 34
Cefis, M., Marcangeli, V., Hammad, R., Granet, J., Leduc‐Gaudet, J., Gaudreau, P., Trumpff, C., Huang, Q., Picard, M. A., Aubertin‐Leheudre, M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101968 · Cited by 26
Aliyu, U., Toor, S. M., Abdalhakam, I., Elrayess, M. A., Samra, A. B. A., & Albagha, O. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1591677 · Cited by 32
[Obesity associated metabolic impairment is evident at early ages: Spanish collaborative study].
Martos‐Moreno, G. Á., Gil‐Campos, M., Bueno, G., Bahillo-Curieses, P., Bernal, S., Feliu, A., Lechuga-Sancho, A. M., Atance, E. P., Ruiz, R., & Vela, A. (2014) · PubMed · doi:10.3305/nh.2014.30.4.7661 · Cited by 27
Metabolic alterations in morbid obesity. Influence on the haemorheological profile
Vayá, A., Hernández‐Mijares, A., Suescún, M., Solá, E., Cámara, R., Romagnoli, M., Bautista, D., & Laíz, B. (2011) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2011-1417 · Cited by 26
Hirata, T., Higashiyama, A., Kubota, Y., Nishimura, K., Sugiyama, D., Kadota, A., Nishida, Y., Imano, H., Nishikawa, T., Miyamatsu, N., et al. (2015) · Journal of Epidemiology · doi:10.2188/jea.je20140172 · Cited by 27
CE‐MS‐based serum fingerprinting to track evolution of type 2 diabetes mellitus
Ciborowski, M., Adamska-Patruno, E., Rusak, M., Godzień, J., Wilk, J., Citko, A., Bauer, W., Górska, M., & Kretowski, A. J. (2015) · Electrophoresis · doi:10.1002/elps.201500021 · Cited by 26
Liao, H.-Y., Sun, M.-F., Lin, J., Chang, S., & Lee, Y. (2015) · Acupuncture in Medicine · doi:10.1136/acupmed-2014-010724 · Cited by 26
Effect of vitamin E on alloxan-induced mouse diabetes
Kamimura, W., Doi, W., Takemoto, K., Ishihara, K., Wang, D.-H., Sugiyama, H., Oda, S.-I., & Masuoka, N. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.02.016 · Cited by 27
Extended High Frequency Audiometry in Polycystic Ovary Syndrome
Kucur, C., Kucur, S. K., Gözükara, İ., Seven, A., Yüksel, K. B., Keskın, N., & Oğhan, F. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/482689 · Cited by 27
Hashimoto, S., Hayashi, S., Yoshida, A., & Naito, M. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14639 · Cited by 26
Andreoli, M. F., Stoker, C., Rossetti, M. F., Alzamendi, A., Castrogiovanni, D. C., Luque, E. H., & Ramos, J. G. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.002 · Cited by 26
Insulin secretory function in Type 2 diabetes: Does it matter how you measure it?
Reaven, G. M. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00016.x · Cited by 26
Acquah, S., Boampong, J. N., Eghan, B., & Eriksson, M. (2014) · Malaria Research and Treatment · doi:10.1155/2014/136148 · Cited by 28
Effects of Sleeve Gastrectomy on Lipid Metabolism in an Obese Diabetic Rat Model
Kawano, Y., Ohta, M., Hirashita, T., Masuda, T., Inomata, M., & Kitano, S. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1035-7 · Cited by 27
One-Year High Fat Diet Affects Muscle-But Not Brain Mitochondria
Jørgensen, T., Grunnet, N., & Quistorff, B. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.27 · Cited by 26
Differences in Insulin Resistance in Mexican and U.S. Pima Indians with Normal Glucose Tolerance
Esparza‐Romero, J., Valencia, M. E., Martínez, M. E., Ravussin, É., Schulz, L. O., & Bennett, P. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0297 · Cited by 29
Central adiposity and decreased heart rate variability in postmenopause: a cross-sectional study
Franz, R. F., Maturana, M. A., Magalhães, J. A. D. A., Moraes, R. S., & Spritzer, P. M. (2012) · Climacteric · doi:10.3109/13697137.2012.745123 · Cited by 26
Damsgaard, C. T., Eidner, M. B., Stark, K. D., Hjorth, M. F., Sjödin, A. M., Andersen, M. R., Andersen, R., Tetens, I., Astrup, A. V., Michaelsen, K. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109368 · Cited by 26
Awotedu, K. O., Ekpebegh, C. O., Longo‐Mbenza, B., & Iputo, J. E. (2010) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2010.09.002 · Cited by 26
Berezin, A. Е., & Kremzer, A. A. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.07.001 · Cited by 26
Marchionne, E. M., Diamond-Stanic, M. K., Prasonnarong, M., & Henriksen, E. J. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00448.2011 · Cited by 27
Machado, S. R., Parise, E. R., & de Carvalho, L. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.09.001 · Cited by 26
High dietary salt decreases antioxidant defenses in the liver of fructose-fed insulin-resistant rats
Dornas, W. C., de Lima, W. G., dos Santos, R. C., Guerra, J. F. D. C., de Souza, M. O., Silva, M., Silva, L. S. E., Diniz, M. F., & Silva, M. E. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.06.006 · Cited by 26
Ryan, A. S., Katzel, L. I., Prior, S. J., McLenithan, J. C., Goldberg, A. P., & Ortmeyer, H. K. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt200 · Cited by 27
Pham, T., Ekwaru, J. P., Loehr, S., & Veugelers, P. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141081 · Cited by 26
Deetman, P. E., Bakker, S. J. L., Kwakernaak, A. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090886 · Cited by 26
Qin, Y., & Tian, Y. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-120 · Cited by 25
Penna‐de‐Carvalho, A., Graus‐Nunes, F., Matheus, J. R. V., Mandarim‐de‐Lacerda, C. A., & Souza‐Mello, V. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.081596 · Cited by 26
Genç, H., Doğru, T., Tapan, S., Kara, M., Erçin, C. N., Aslan, F., Kantarcıoğlu, M., Karslıoğlu, Y., Sertoğlu, E., Erbil, M. K., et al. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.603163 · Cited by 26
Şahin, S., Eroğlu, M., Selcuk, S., Turkgeldi, L. S., Kozalı, Ş., Davutoğlu, S., & Muhçu, M. (2014) · PubMed · Cited by 26
Metabolic endotoxaemia in childhood obesity
Varma, M. C., Kusminski, C. M., Azharian, S., Gilardini, L., Kumar, S., Invitti, C., & McTernan, P. G. (2015) · BMC Obesity · doi:10.1186/s40608-016-0083-7 · Cited by 29
Sun, W., Zeng, C., Liao, L., Chen, J., & Wang, Y. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1176013 · Cited by 27
Verboven, K., Hansen, D., Moro, C., Eijnde, B. O., Hoebers, N., Knol, J., Bouckaert, W., Dams, A., Blaak, E. E., & Jocken, J. W. E. (2016) · Clinical Science · doi:10.1042/cs20160220 · Cited by 25
Li, Q., & Xing, B. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0103 · Cited by 26
Insulin Resistance Is a Risk Factor for Increased Intraocular Pressure: The Hisayama Study
Fujiwara, K., Yasuda, M., Ninomiya, T., Hata, J., Hashimoto, S., Yoshitomi, T., Kiyohara, Y., & Ishibashi, T. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16766 · Cited by 26
Zhou, M., Zhu, L., Cui, X., Feng, L., Zhao, X., He, S., Ping, F., Li, W., & Li, Y. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2814 · Cited by 26
High pulse pressure is related to risk of type 2 diabetes mellitus in Chinese middle-aged females
Zhang, L., Wang, B., Wang, C., Li, L., Ren, Y., Zhang, H., Yang, X., Zhao, Y., Han, C., Zhou, J., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.233 · Cited by 26
Santalahti, K., Maksimow, M., Airola, A., Pahikkala, T., Hutri‐Kähönen, N., Jalkanen, S., Raitakari, O. T., & Salmi, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2081 · Cited by 26
Kaur, A., Johnston, D. G., & Godsland, I. F. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0095 · Cited by 26
Prediction of hard cardiovascular events in HIV patients
Raggi, P., Francesco, D. D., Manicardi, M., Zona, S., Bellasi, A., Stentarelli, C., Carli, F., Beghetto, B., Mussini, C., Malagoli, A., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw346 · Cited by 26
Sakai, S., Tanimoto, K., Imbe, A., Inaba, Y., Shishikura, K., Tanimoto, Y., Ushiroyama, T., Terasaki, J., & Hanafusa, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162603 · Cited by 28
Šimunović, M., Božić, J., Milić, L., Unic, I. J., & Škrabić, V. (2016) · International Journal of Endocrinology · doi:10.1155/2016/1823561 · Cited by 26
Duration of Fasting, Serum Lipids, and Metabolic Profile in Early Childhood
Anderson, L. N., Maguire, J. L., Lebovic, G., Hanley, A. J., Hamilton, J. K., Adeli, K., McCrindle, B. W., Borkhoff, C. M., Parkin, P. C., & Birken, C. S. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.09.005 · Cited by 28
Reduced muscle mass in middle-aged depressed patients is associated with male gender and chronicity
Kahl, K. G., Utanir, F., Schweiger, U., Krüger, T. H. C., Frieling, H., Bleich, S., Gutberlet, M., & Hartung, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.009 · Cited by 26
Paschou, S. Α., Palioura, E., Ioannidis, D., Anagnostis, P. G., Panagiotakou, A., Loi, V., Karageorgos, G., Goulis, D. G., & Vryonidou, A. (2017) · Endocrine Connections · doi:10.1530/ec-17-0239 · Cited by 26
Ferguson, T., Younger-Coleman, N., Tulloch-Reid, M., Bennett, N., Rousseau, A., Knight-Madden, J., Samms-Vaughan, M., Ashley, D., & Wilks, R. (2018) · PeerJ · doi:10.7717/peerj.4385 · Cited by 25
Lin, T., Lim, P., & Hung, S. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy006 · Cited by 26
MC4R variant rs17782313 and manifestation of obese phenotype in Pakistani females
Rana, S., Rahmani, S., & Mirza, S. (2018) · RSC Advances · doi:10.1039/c8ra00695d · Cited by 26
Kim, J. A., Hwang, S. Y., Chung, H. S., Kim, N. H., Seo, J. A., Kim, S. G., Kim, N. H., Choi, K. M., Baik, S. H., & Yoo, H. J. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0036 · Cited by 26
Harrat, N. E. I., Louala, S., Bensalah, F., Affane, F., Chekkal, H., & Lamri‐Senhadji, M. (2018) · Nutrition & Food Science · doi:10.1108/nfs-06-2018-0169 · Cited by 26
Drummen, M., Dorenbos, E., Vreugdenhil, A. C. E., Stratton, G., Raben, A., Westerterp‐Plantenga, M. S., & Adam, T. C. (2018) · Nutrients · doi:10.3390/nu10111771 · Cited by 27
El‐Ashmawy, H. M., & Ahmed, A. M. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001354 · Cited by 26
Vázquez-Bourgón, J., Setién‐Suero, E., Pilar-Cuéllar, F., Romero-Jiménez, R., de la Foz, V. O., Castro, E., & Crespo‐Facorro, B. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881118822173 · Cited by 26
Peris‐Sampedro, F., Mounib, M., Schéle, E., Edvardsson, C. E., Stoltenborg, I., Adan, R. A. H., & Dickson, S. L. (2019) · Obesity · doi:10.1002/oby.22381 · Cited by 29
Ali, E. M. M., Diab, T. A., Elsaid, A. M. M., Daim, H. A. A. E., Elshazli, R. M., & Settin, A. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1573841 · Cited by 26
Desai, T., Roberts, M. G., & Bottoms, L. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.04.005 · Cited by 27
Obesity and Risk of Peptic Ulcer Disease: A Large-Scale Health Check-Up Cohort Study
Pyo, J. H., Lee, H., Kim, J. E., et al. (2019) · Nutrients · doi:10.3390/nu11061288 · Cited by 26
Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome
Subramaniam, K., Vipin, V. P., Kapoor, A., et al. (2019) · Human Reproduction · doi:10.1093/humrep/dez104 · Cited by 26
Wang, C. W., Chuang, H., Liao, K., Yu, M., Dai, C. Y., Chang, W., Tsai, C. H., Chiang, H. C., & Huang, P. (2019) · Environment International · doi:10.1016/j.envint.2019.104978 · Cited by 26
Tatsumi, Y., Morimoto, A., Asayama, K., Sonoda, N., Miyamatsu, N., Ohno, Y., Miyamoto, Y., Izawa, S., & Ohkubo, T. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz123 · Cited by 26
Weingarten, M. F. J., Scholz, M. R., Wohland, T., Horn, K., Stümvoll, M., Kovacs, P. L., & Tönjes, A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00643 · Cited by 28
Liu, Q., Wang, S., Wei, M., Huang, X., Cheng, Y., Shao, Y., Xia, P., Zhong, M., Liu, S., Zhang, G., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00566 · Cited by 27
Association of Retinopathy and Insulin Resistance: NHANES 2005-2008
Bao, Y. K., Yan, Y., Wilson, B. S., Gordon, M. O., Semenkovich, C. F., & Rajagopal, R. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1659977 · Cited by 26
Larsen, M. A., Isaksen, V. T., Paulssen, E. J., Goll, R., & Florholmen, J. R. (2019) · Endocrine · doi:10.1007/s12020-019-02102-9 · Cited by 28
Farhangi, M. A., Vajdi, M., Nikniaz, L., & Nikniaz, Z. (2019) · Lifestyle Genomics · doi:10.1159/000503789 · Cited by 26
Karras, S. Ν., Koufakis, T., Tsekmekidou, X., Antonopoulou, V., Zebekakis, P. E., & Kotsa, K. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107985 · Cited by 26
Ojeda‐Granados, C., Panduro, A., Rivera‐Íñiguez, I., Sepúlveda-Villegas, M., & Román, S. (2020) · Nutrients · doi:10.3390/nu12030645 · Cited by 31
Wu, D., Yang, X., Zhong, P., Ye, X., Li, C., & Liu, X. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317520912126 · Cited by 27
Baziar, N., Nasli‐Esfahani, E., Djafarian, K., Qorbani, M., Hedayati, M., Mishani, M. A., Faghfoori, Z., Ahmaripour, N., & Hosseini, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5850865 · Cited by 28
Gennari, A., Foca, F., Zamarchi, R., Rocca, A., Amadori, D., DeCensi, A., Bologna, A., Cavanna, L., Gianni, L., Scaltriti, L., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05596-4 · Cited by 27
Singh, S., Panda, V., Sudhamani, S., et al. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.06.002 · Cited by 26
Leptin level as a biomarker of uncontrolled eating in obesity and overweight
Benbaibeche, H., Bounihi, A., & Koceir, E.-A. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02316-1 · Cited by 28
Lotfollahi, Z., Mello, A. P. D. Q., Costa, E. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69288-1 · Cited by 26
Climax, J., Newsome, P. N., Hamza, M., Weissbach, M., Coughlan, D., Sattar, N. A., McGuire, D. K., & Bhatt, D. L. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.016334 · Cited by 26
Özkur, E., Erdem, Y., Altunay, İ. K., Demіr, D., Dolu, N. Ç., Serin, E., & Çerman, A. A. (2020) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2020.04.009 · Cited by 25
Regulation of lymphatic function and injury by nitrosative stress in obese mice
Rehal, S., Kataru, R. P., Hespe, G. E., Baik, J. E., Park, H. J., Ly, C. L., Shin, J., & Mehrara, B. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101081 · Cited by 29
Skeletal muscle IGF-1 is lower at rest and after resistance exercise in humans with obesity
Sullivan, B. P., Weiss, J. A., Nie, Y., Garner, R. T., Drohan, C. J., Kuang, S., Stout, J., & Gavin, T. P. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04509-z · Cited by 26
Kim, W., Go, T., Kang, D. R., Lee, E. J., & Huh, J. H. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107760 · Cited by 30
Byun, J., Cha, K. S., Jun, J. E., Kim, T., Jung, K., Jeong, I., & Shin, W. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-74908-x · Cited by 26
Seral-Cortés, M., Sabroso‐Lasa, S., Miguel‐Etayo, P. D., González‐Gross, M., Gesteiro, E., Molina‐Hidalgo, C., Henauw, S. D., Erhardt, É., Censi, L., Μanios, Y., et al. (2020) · Nutrients · doi:10.3390/nu12123841 · Cited by 27
Bishay, R. H., Tonks, K. T. T., George, J., Samocha‐Bonet, D., Meyerowitz‐Katz, G., Chisholm, D. J., James, D. E., & Greenfield, J. R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa940 · Cited by 26
Yokota, T., Kinugawa, S., Hirabayashi, K., Yamato, M., Takada, S., Suga, T., Nakano, I., Fukushima, A., Matsushima, S., Okita, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81736-0 · Cited by 27
Morioka, T., Mori, K., & Emoto, M. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17047 · Cited by 26
Li, S., Lu, J., Gu, G., Bai, W., Ye, Y., Bao, Y., Yu, H., & Han, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.664100 · Cited by 26
Circulating prolactin level is increased in metabolically healthy obesity
Liu, J., Zhang, L., Fu, J. H., Wang, Q., & Wang, G. (2021) · Endocrine Connections · doi:10.1530/ec-21-0040 · Cited by 25
Azizi, S., Mahdavi, R., Mobasseri, M., Aliasgharzadeh, S., Abbaszadeh, F., & Ebrahimi‐Mameghani, M. (2021) · Phytotherapy Research · doi:10.1002/ptr.6997 · Cited by 27
Wang, L., Luo, X., Wang, Q., et al. (2021) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2021.32.e70 · Cited by 26
Relationship between serum total testosterone and prostate volume in aging men
Xia, B., Zhao, S., Chen, Z., Chen, C., Liu, T., Yang, F., & Yan, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-93728-1 · Cited by 27
Relationship between the Plasma Proteome and Changes in Inflammatory Markers after Bariatric Surgery
Fachim, H., Iqbal, Z., Gibson, M., Baričević-Jones, I., Campbell, A. E., Geary, B., Syed, A. A., Whetton, A. D., Soran, H., Donn, R. P., et al. (2021) · Cells · doi:10.3390/cells10102798 · Cited by 25
Time-Restricted Feeding Restores Obesity-Induced Alteration in Adipose Tissue Immune Cell Phenotype
Lee, Y., Kim, Y., Lee, M., Wu, D., & Pae, M. (2021) · Nutrients · doi:10.3390/nu13113780 · Cited by 26
Hamaoka, T., Murai, H., Hirai, T., Sugimoto, H., Mukai, Y., Inoue, O., Takashima, S., Kato, T., Takata, S., Usui, S., et al. (2021) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.121.022637 · Cited by 23
Histone acetyltransferase NAA40 modulates acetyl-CoA levels and lipid synthesis
Charidemou, E., Tsiarli, M. A., Theophanous, A., Yılmaz, V., Pitsouli, C., Strati, K., Griffin, J. L., & Kirmizis, A. (2022) · BMC Biology · doi:10.1186/s12915-021-01225-8 · Cited by 26
Brandl, B., Rennekamp, R., Reitmeier, S., Pietrynik, K., Dirndorfer, S., Haller, D., Hofmann, T., Skurk, T., & Hauner, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.816299 · Cited by 27
Prasad, M., Jayaraman, S., Rajagopal, P., Veeraraghavan, V. P., Kumar, P., Piramanayagam, S., & Pari, L. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109885 · Cited by 27
Wang, Z., Li, W. L., Li, J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.889379 · Cited by 26
Hendawy, A. S., El-Lakkany, N. M., Mantawy, E. M., Hammam, O. A., Botros, S. S., & El‐Demerdash, E. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120695 · Cited by 28
Lee, J., Kwon, Y., Park, K., et al. (2022) · Nutrients · doi:10.3390/nu14153039 · Cited by 26
Nikbaf‐Shandiz, M., Tutunchi, H., Khoshbaten, M., Nazari‐Bonab, H., & Ebrahimi‐Mameghani, M. (2022) · Food & Function · doi:10.1039/d2fo01280d · Cited by 26
Roy, J. R., Janaki, C. S., Jayaraman, S., Vijayalakshmi, P., Balaji, T., Vijayamalathi, M., & Veeraraghavan, V. P. (2022) · Antioxidants · doi:10.3390/antiox11102081 · Cited by 28
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
